Home/Pipeline/Sana Device for Neuropathic Pain

Sana Device for Neuropathic Pain

Neuropathic Pain

Pivotal Trial CompletedActive

Key Facts

Indication

Neuropathic Pain

Phase

Pivotal Trial Completed

Status

Active

Company

Sana Health

About Sana Health

Sana Health is a clinical-stage digital therapeutics company built on a founder's personal quest to overcome debilitating chronic pain. Its core technology is a wearable audiovisual device designed to modulate neural pathways to provide relief from conditions such as neuropathic pain and PTSD. The company has achieved significant regulatory milestones, including FDA Breakthrough Device Designation and submission of pivotal De Novo data for neuropathic pain, positioning it for potential market entry in a major indication. Backed by defense funding and a veteran team, Sana is advancing a pipeline focused on large, underserved neurological and psychiatric conditions.

View full company profile

Therapeutic Areas

Chronic Pain Psychiatry

Other Neuropathic Pain Drugs

Drug	Company	Phase	Status
Peripheral nerve pain agent	Nyrada	Preclinical	Active
NTRX-07	NeuroTherapia	Pre-clinical	Active
Neuropathic Pain Model Service	NeuroProof	Pre-clinical	Active
Neuropathic Pain Program	VersaPeutics	Preclinical	Active
Cerebro Platform for Pain	Vonova.io	Pre-clinical	Active
LAT9997	Lateral Pharma	Phase 2 (next-gen)	Active; composition-of-matter patent secured
ZYNPN	Zyneyro	Pre-clinical	Active
XT-150 (Preclinical)	Xalud Therapeutics	Preclinical	Active
ONO-2910	Ono Pharmaceutical	Phase 2	Active
VX-548	Vertex Pharmaceuticals	Phase 2	Active
BDT272	KYORIN Pharmaceutical	Preclinical	Active (In-licensed)
HSK16149	Haisco Pharmaceutical Group	Phase III	Active